Mariner, LLC Homology Medicines, Inc. Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.83 - $1.12 $63 - $86	-77 Reduced 0.39%	19,833 $17,000
Q1 2023 May 12, 2023	SELL	$0.91 - $1.69 $447 - $831	-492 Reduced 2.41%	19,910 $21,000
Q4 2022 Feb 14, 2023	SELL	$1.09 - $2.04 $3,889 - $7,278	-3,568 Reduced 14.89%	20,402 $26,000
Q3 2022 Nov 10, 2022	BUY	$1.55 - $3.01 $37,153 - $72,149	23,970 New	23,970 $39,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.